Title
a. Authorize the Director of Health Services or their designee to execute Amendment No. 5 to Apexus 340B Prime Vendor Program Participation Agreement ("Letter of Participation") with Cardinal Health 110, LLC. and Cardinal Health 112, LLC. (Cardinal) for the purchase of discounted outpatient pharmaceuticals, to extend the term three (3) additional years for a revised full term of July 1, 2018 through August 31, 2026, with the option to extend, based on ninety (90) days' written notice, for one (1) additional three (3) year period; and
b. Authorize the Director of Health Services or their designee to sign up to three (3) future amendments to this Letter of Participation where the amendments do not extend the term of the Letter of Participation and do not significantly change the scope of work; and
c. Authorize the Director of Health Services or their designee to exercise the option to extend, based on ninety (90) days' written notice, which, if exercised, shall extend the term for one (1) additional three (3) year period, for a revised full term of July 1, 2018, to August 31, 2029.
Report
RECOMMENDATION:
It is recommended that the Board of Supervisors:
a. Authorize the Director of Health Services or their designee to execute Amendment No. 5 to Apexus 340B Prime Vendor Program Participation Agreement ("Letter of Participation") with Cardinal Health 110, LLC. and Cardinal Health 112, LLC. (Cardinal) for the purchase of discounted outpatient pharmaceuticals, to extend the term three (3) additional years for a revised full term of July 1, 2018 through August 31, 2026, with the option to extend, based on ninety (90) days' written notice, for one (1) additional three (3) year period; and
b. Authorize the Director of Health Services or their designee to sign up to three (3) future amendments to this Letter of Participation where the amendments do not extend the term of the Letter of Participation and do not significantly change the scope of work; and
c. Authori...
Click here for full text